Cancer immunotherapies
delivered from within.

Empowering the body to make its own cancer treatment

Our disruptive approach holds the potential to transform standards of cell and gene therapies for cancer treatment.

Improving cancer patient’s journey with in vivo engineered CAR-T cells

  • It accelerates access to treatment.
  • It makes treatment administration easier.
  • It enables significant costs reduction.
  • It prevents host vs. graft rejection.
  • It simplifies hospitals processes.

A game-changing biotech company led by seasoned experts

Ready to join the team?

We are building an international and diverse team of passionate researchers with solid background, amongst others, in cancer immunotherapy, cell & gene therapies, protein engineering, immunology, and virology.